Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,040 | 10,990 | -11,400 | -5,990 | -6,080 |
| Depreciation Amortization | 470 | 500 | 260 | 160 | 140 |
| Other Working Capital | -1,140 | 3,100 | -510 | -130 | 310 |
| Other Operating Activity | 0 | -30,130 | 10 | 240 | 200 |
| Operating Cash Flow | $-13,710 | $-15,540 | $-11,640 | $-5,720 | $-5,430 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -160 | -30 | -940 | -80 | -250 |
| Other Investing Activity | 0 | 30,380 | -250 | 10,300 | -6,480 |
| Investing Cash Flow | $-160 | $30,350 | $-1,190 | $10,220 | $-6,730 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -1 | -1 | -1 | 0 | -3 |
| Other Financing Activity | 3,301 | 1,551 | 751 | 13,390 | 13,083 |
| Financing Cash Flow | $3,300 | $1,550 | $750 | $13,390 | $13,080 |
| Beginning Cash Position | 23,280 | 6,920 | 19,010 | 1,110 | 200 |
| End Cash Position | 12,700 | 23,280 | 6,920 | 19,010 | 1,110 |
| Net Cash Flow | $-10,570 | $16,360 | $-12,090 | $17,890 | $910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,710 | -15,540 | -11,640 | -5,720 | -5,430 |
| Free Cash Flow | -13,710 | -15,540 | -11,640 | -5,720 | -5,430 |